MASP2 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

11 results for “MASP2”

Trials

Magnesium Sulphate for Preterm Birth (MASP Study)

560 participants · First posted Dec 15, 2011

A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2)

121 participants · First posted Sep 4, 2019

Drugs

anti-MASP2 antibody (Jiangsu Hengrui)

MSP2-C1

MASP-3 inhibitors

News

IgA Nephropathy Pipeline Shows Robust Growth with 30+ Therapies in Development

Omeros' Zaltenibart Receives FDA Rare Pediatric Disease Designation for C3 Glomerulopathy

Omeros' Zaltenibart Receives FDA Rare Pediatric Disease Designation for C3 Glomerulopathy

Page 1 of 2